PRPO
Precipio, Inc.
Price Chart
Latest Quote
$22.45
-0.13 (-0.58%)
Current Price
| Previous Close | $22.58 |
| Open | $22.40 |
| Day High | $22.92 |
| Day Low | $22.16 |
| Volume | 38,776 |
Stock Information
| Shares Outstanding | 1.79M |
| Total Debt | $3.49M |
| Cash Equivalents | $2.60M |
| Revenue | $25.83M |
| Net Income | $-922K |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Market Cap | $40.13M |
| EPS (TTM) | $-0.45 |
| Exchange | NCM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $41.01M |
| Sales | $25.83M |
| Income | $-922K |
| Book/sh | $7.94 |
| Cash/sh | $1.46 |
| Employees | 61 |
Financial Ratios
| Quick Ratio | 1.21 |
| Current Ratio | 1.56 |
| Debt/Eq | 24.65 |
Returns & Margins
| ROA | -5.74% |
| ROE | -7.13% |
| Gross Margin | 43.71% |
| Operating Margin | -21.28% |
| Profit Margin | -3.57% |
Ownership
| Insider Ownership | 11.80% |
| Institutional Ownership | 17.62% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | 57.56 |
| P/S | 1.55 |
| P/B | 2.83 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $23.04 |
| SMA50 | $26.35 |
| SMA200 | $23.61 |
| RSI | 46.88 |
| ATR | 1.2938 |
| Shares Float | 1.43M |
| Short Float | 0.77% |
| Short Ratio | 0.34 |
| Rel Volume | 1.20 |
Performance History
| Week | -0.80% |
| Month | -9.04% |
| Quarter | -16.64% |
| 6 Months | -6.54% |
| YTD | -5.75% |
| Year | +102.25% |
| 3 Years | +149.44% |
| 5 Years | -70.84% |
| 10 Years | -99.17% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-18 | $22.45 | 38,800 |
| 2026-06-17 | $22.36 | 34,500 |
| 2026-06-16 | $22.25 | 58,800 |
| 2026-06-15 | $22.44 | 13,100 |
| 2026-06-12 | $22.10 | 24,800 |
| 2026-06-11 | $22.63 | 12,300 |
| 2026-06-10 | $22.55 | 13,100 |
| 2026-06-09 | $23.32 | 24,800 |
| 2026-06-08 | $23.00 | 39,300 |
| 2026-06-05 | $23.49 | 22,900 |
| 2026-06-04 | $23.36 | 22,800 |
| 2026-06-03 | $24.04 | 62,100 |
| 2026-06-02 | $22.48 | 65,800 |
| 2026-06-01 | $22.53 | 23,900 |
| 2026-05-29 | $22.80 | 30,300 |
| 2026-05-28 | $23.34 | 33,300 |
| 2026-05-27 | $23.55 | 39,900 |
| 2026-05-26 | $23.80 | 43,300 |
| 2026-05-22 | $23.80 | 21,100 |
| 2026-05-21 | $24.56 | 21,000 |
| 2026-05-20 | $24.06 | 31,500 |
| 2026-05-19 | $24.68 | 59,100 |
About Precipio, Inc.
Precipio, Inc., a healthcare biotechnology company, provides cancer diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers HemeScreen, a suite of robust genetic diagnostic panels; and IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages. It offers biomarker testing and clinical project services to bio-pharma customers. Precipio, Inc. is based in New Haven, Connecticut.
đ° Latest News
Precipio (PRPO) Q1 2026 Earnings Call Transcript
Motley Fool âĸ 2026-06-02T16:54:55Z
Precipio (PRPO) Q4 2025 Earnings Transcript
Motley Fool âĸ 2026-06-02T16:15:12Z
Precipio Stock Slips Post Q1 Earnings Despite Revenue Growth
Zacks âĸ 2026-05-22T14:27:00Z
Precipio Inc (PRPO) Q1 2026 Earnings Call Highlights: Revenue Growth Amidst Margin Challenges
GuruFocus.com âĸ 2026-05-21T01:01:54ZThe Zacks Analyst Blog NVIDIA, Mastercard, AbbVie, Waterstone and Precipio
Zacks âĸ 2026-05-13T10:12:00Z
Top Stock Reports for NVIDIA, Mastercard & AbbVie
Zacks âĸ 2026-05-12T20:28:00Z
Precipio, Inc. Q4 2025 Earnings Call Summary
Moby âĸ 2026-03-31T12:30:00Z
Top Stock Reports for AbbVie, Coca-Cola & Chevron
Zacks âĸ 2025-12-24T18:10:00Z
Precipio Stock Up Following Solid Q3 Earnings and Improved Cash Flow
Zacks âĸ 2025-11-19T16:34:00Z
Precipio Inc (PRPO) Q3 2025 Earnings Call Highlights: Record Revenue Growth and Strategic ...
GuruFocus.com âĸ 2025-11-18T05:01:04Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $13,343,000 | $10,973,000 | $9,179,000 | $6,902,000 |
| Cost Of Revenue | $13,343,000 | $10,973,000 | $9,179,000 | $6,902,000 |
| Total Revenue | $24,049,000 | $18,532,000 | $15,197,000 | $9,412,000 |
| Operating Revenue | $24,246,000 | $18,576,000 | $15,415,000 | $8,418,000 |
| Expenses | ||||
| Interest Expense | $73,000 | $74,000 | $18,000 | $12,000 |
| Total Expenses | $25,251,000 | $22,748,000 | $22,817,000 | $22,209,000 |
| Other Income Expense | $912,000 | - | $1,785,000 | $631,000 |
| Other Non Operating Income Expenses | $123,000 | - | $65,000 | $25,000 |
| Net Non Operating Interest Income Expense | $-73,000 | $-74,000 | $-18,000 | $-12,000 |
| Interest Expense Non Operating | $73,000 | $74,000 | $18,000 | $12,000 |
| Operating Expense | $11,908,000 | $11,775,000 | $13,638,000 | $15,307,000 |
| Other Operating Expenses | $11,908,000 | $11,775,000 | $13,638,000 | $15,307,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-363,000 | $-4,290,000 | $-5,853,000 | $-12,203,000 |
| Net Interest Income | $-73,000 | $-74,000 | $-18,000 | $-12,000 |
| Normalized Income | $-1,152,000 | $-4,290,000 | $-7,573,000 | $-12,834,000 |
| Net Income From Continuing And Discontinued Operation | $-363,000 | $-4,290,000 | $-5,853,000 | $-12,203,000 |
| Total Operating Income As Reported | $-1,202,000 | $-4,216,000 | $-7,620,000 | $-12,797,000 |
| Net Income Common Stockholders | $-363,000 | $-4,290,000 | $-5,853,000 | $-12,203,000 |
| Net Income | $-363,000 | $-4,290,000 | $-5,853,000 | $-12,203,000 |
| Net Income Including Noncontrolling Interests | $-363,000 | $-4,290,000 | $-5,853,000 | $-12,178,000 |
| Net Income Continuous Operations | $-363,000 | $-4,290,000 | $-5,853,000 | $-12,178,000 |
| Pretax Income | $-363,000 | $-4,290,000 | $-5,853,000 | $-12,178,000 |
| Special Income Charges | $789,000 | $0 | $1,720,000 | $25,000 |
| Gross Profit | $10,706,000 | $7,559,000 | $6,018,000 | $2,510,000 |
| Per Share | ||||
| Diluted EPS | $-0.23 | $-2.93 | $-4.51 | $-10.73 |
| Basic EPS | $-0.23 | $-2.93 | $-4.51 | $-10.73 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $673,000 | $-2,703,000 | $-6,038,000 | $-11,277,000 |
| Total Unusual Items | $789,000 | $0 | $1,720,000 | $631,000 |
| Total Unusual Items Excluding Goodwill | $789,000 | $0 | $1,720,000 | $631,000 |
| Reconciled Depreciation | $1,752,000 | $1,513,000 | $1,517,000 | $1,520,000 |
| EBITDA (Bullshit earnings) | $1,462,000 | $-2,703,000 | $-4,318,000 | $-10,646,000 |
| EBIT | $-290,000 | $-4,216,000 | $-5,835,000 | $-12,166,000 |
| Diluted Average Shares | $1,605,080 | $1,465,518 | $1,297,851 | $1,137,573 |
| Basic Average Shares | $1,605,080 | $1,465,518 | $1,297,851 | $1,137,573 |
| Diluted NI Availto Com Stockholders | $-363,000 | $-4,290,000 | $-5,853,000 | $-12,203,000 |
| Tax Provision | $0 | $0 | $0 | $0 |
| Other Special Charges | $-789,000 | - | $-1,720,000 | $-25,000 |
| Minority Interests | - | - | $0 | $-25,000 |
| Gain On Sale Of Security | - | - | - | $606,000 |
Fetched: 2026-06-18
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $3,642,000 | $225,000 | $1,611,000 | $2,534,000 |
| Total Assets | $21,317,000 | $16,996,000 | $18,101,000 | $21,504,000 |
| Total Non Current Assets | $15,278,000 | $13,545,000 | $14,419,000 | $15,794,000 |
| Other Non Current Assets | $67,000 | $45,000 | $76,000 | $129,000 |
| Goodwill And Other Intangible Assets | $10,919,000 | $11,869,000 | $12,818,000 | $13,768,000 |
| Other Intangible Assets | $10,919,000 | $11,869,000 | $12,818,000 | $13,768,000 |
| Current Assets | $6,039,000 | $3,451,000 | $3,682,000 | $5,710,000 |
| Other Current Assets | $469,000 | $539,000 | $495,000 | $521,000 |
| Inventory | $935,000 | $724,000 | $384,000 | $708,000 |
| Receivables | $1,984,000 | $799,000 | $1,301,000 | $1,036,000 |
| Accounts Receivable | $1,984,000 | $799,000 | $1,301,000 | $1,036,000 |
| Allowance For Doubtful Accounts Receivable | $-1,045,000 | $-995,000 | $-2,572,000 | $-2,354,000 |
| Gross Accounts Receivable | $3,029,000 | $1,794,000 | $3,873,000 | $3,390,000 |
| Cash Cash Equivalents And Short Term Investments | $2,651,000 | $1,389,000 | $1,502,000 | $3,445,000 |
| Cash And Cash Equivalents | $2,651,000 | $1,389,000 | $1,502,000 | $3,445,000 |
| Cash Financial | $2,651,000 | $1,389,000 | $1,502,000 | $3,445,000 |
| Debt | ||||
| Total Debt | $3,653,000 | $1,253,000 | $1,116,000 | $1,392,000 |
| Long Term Debt And Capital Lease Obligation | $3,004,000 | $631,000 | $531,000 | $776,000 |
| Long Term Debt | $47,000 | $77,000 | $106,000 | $134,000 |
| Current Debt And Capital Lease Obligation | $649,000 | $622,000 | $585,000 | $616,000 |
| Current Debt | $30,000 | $297,000 | $235,000 | $255,000 |
| Other Current Borrowings | $30,000 | $297,000 | $235,000 | $255,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $6,756,000 | $4,902,000 | $3,672,000 | $5,137,000 |
| Total Non Current Liabilities Net Minority Interest | $3,004,000 | $631,000 | $531,000 | $776,000 |
| Current Liabilities | $3,752,000 | $4,271,000 | $3,141,000 | $4,361,000 |
| Current Deferred Liabilities | $282,000 | $232,000 | $110,000 | $119,000 |
| Payables And Accrued Expenses | $1,844,000 | $2,462,000 | $1,692,000 | $3,135,000 |
| Interest Payable | $19,000 | $19,000 | $19,000 | $19,000 |
| Payables | $1,340,000 | $791,000 | $909,000 | $2,133,000 |
| Total Tax Payable | $209,000 | $173,000 | $287,000 | $91,000 |
| Accounts Payable | $1,131,000 | $618,000 | $622,000 | $2,042,000 |
| Derivative Product Liabilities | - | - | - | $0 |
| Equity | ||||
| Common Stock Equity | $14,561,000 | $12,094,000 | $14,429,000 | $16,302,000 |
| Total Equity Gross Minority Interest | $14,561,000 | $12,094,000 | $14,429,000 | $16,367,000 |
| Stockholders Equity | $14,561,000 | $12,094,000 | $14,429,000 | $16,302,000 |
| Retained Earnings | $-102,803,000 | $-102,440,000 | $-98,150,000 | $-92,297,000 |
| Other | ||||
| Preferred Shares Number | $2,586,205 | $2,586,205 | $2,586,205 | $2,586,205 |
| Ordinary Shares Number | $1,780,899 | $1,493,639 | $1,420,125 | $1,141,013 |
| Share Issued | $1,780,899 | $1,493,639 | $1,420,125 | $1,141,013 |
| Tangible Book Value | $3,642,000 | $225,000 | $1,611,000 | $2,534,000 |
| Invested Capital | $14,638,000 | $12,468,000 | $14,770,000 | $16,691,000 |
| Working Capital | $2,287,000 | $-820,000 | $541,000 | $1,349,000 |
| Capital Lease Obligations | $3,576,000 | $879,000 | $775,000 | $1,003,000 |
| Total Capitalization | $14,608,000 | $12,171,000 | $14,535,000 | $16,436,000 |
| Additional Paid In Capital | $117,346,000 | $114,519,000 | $112,565,000 | $108,588,000 |
| Capital Stock | $18,000 | $15,000 | $14,000 | $11,000 |
| Common Stock | $18,000 | $15,000 | $14,000 | $11,000 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Long Term Capital Lease Obligation | $2,957,000 | $554,000 | $425,000 | $642,000 |
| Current Deferred Revenue | $282,000 | $232,000 | $110,000 | $119,000 |
| Current Capital Lease Obligation | $619,000 | $325,000 | $350,000 | $361,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $977,000 | $955,000 | $754,000 | $491,000 |
| Current Accrued Expenses | $504,000 | $1,671,000 | $783,000 | $1,002,000 |
| Net PPE | $4,292,000 | $1,631,000 | $1,525,000 | $1,897,000 |
| Accumulated Depreciation | $-1,866,000 | $-1,627,000 | $-1,377,000 | $-1,102,000 |
| Gross PPE | $6,158,000 | $3,258,000 | $2,902,000 | $2,999,000 |
| Construction In Progress | $27,000 | $86,000 | $30,000 | $34,000 |
| Other Properties | $4,796,000 | $1,929,000 | $1,751,000 | $1,951,000 |
| Machinery Furniture Equipment | $1,335,000 | $1,243,000 | $1,121,000 | $1,014,000 |
| Minority Interest | - | $0 | $0 | $65,000 |
Fetched: 2026-06-18
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $359,000 | $216,000 | $-3,685,000 | $-7,998,000 |
| Operating Activities | ||||
| Cash Flow From Continuing Operating Activities | $685,000 | $439,000 | $-3,559,000 | $-7,721,000 |
| Operating Gains Losses | $20,000 | - | $-65,000 | $-606,000 |
| Investing Activities | ||||
| Capital Expenditure | $-326,000 | $-223,000 | $-126,000 | $-277,000 |
| Investing Cash Flow | $-326,000 | $-223,000 | $-126,000 | $-277,000 |
| Cash Flow From Continuing Investing Activities | $-326,000 | $-223,000 | $-126,000 | $-277,000 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $0 | $78,000 | $2,245,000 | $129,000 |
| Financing Cash Flow | $903,000 | $-329,000 | $1,742,000 | $-225,000 |
| Cash Flow From Continuing Financing Activities | $903,000 | $-329,000 | $1,742,000 | $-225,000 |
| Net Common Stock Issuance | $0 | $78,000 | $2,245,000 | $129,000 |
| Common Stock Issuance | $0 | $78,000 | $2,245,000 | $129,000 |
| Net Other Financing Charges | - | - | - | - |
| Other | ||||
| Repayment Of Debt | $-477,000 | $-657,000 | $-503,000 | $-365,000 |
| Issuance Of Debt | $0 | $250,000 | $0 | - |
| Interest Paid Supplemental Data | $100,000 | $85,000 | $42,000 | $45,000 |
| End Cash Position | $2,651,000 | $1,389,000 | $1,502,000 | $3,445,000 |
| Beginning Cash Position | $1,389,000 | $1,502,000 | $3,445,000 | $11,668,000 |
| Changes In Cash | $1,262,000 | $-113,000 | $-1,943,000 | $-8,223,000 |
| Proceeds From Stock Option Exercised | $1,380,000 | $0 | $0 | $11,000 |
| Net Issuance Payments Of Debt | $-477,000 | $-407,000 | $-503,000 | $-365,000 |
| Net Long Term Debt Issuance | $-477,000 | $-407,000 | $-503,000 | $-365,000 |
| Long Term Debt Payments | $-477,000 | $-657,000 | $-503,000 | $-365,000 |
| Long Term Debt Issuance | $0 | $250,000 | $0 | - |
| Net PPE Purchase And Sale | $-326,000 | $-223,000 | $-126,000 | $-277,000 |
| Purchase Of PPE | $-326,000 | $-223,000 | $-126,000 | $-277,000 |
| Change In Working Capital | $-2,169,000 | $1,270,000 | $606,000 | $-643,000 |
| Change In Other Working Capital | $50,000 | $122,000 | $-9,000 | $101,000 |
| Change In Other Current Liabilities | $-241,000 | $-218,000 | $-206,000 | $-182,000 |
| Change In Other Current Assets | $48,000 | $303,000 | $451,000 | $491,000 |
| Change In Payables And Accrued Expense | $-453,000 | $965,000 | $529,000 | $-164,000 |
| Change In Accrued Expense | $-966,000 | $975,000 | $698,000 | $-329,000 |
| Change In Payable | $513,000 | $-10,000 | $-169,000 | $165,000 |
| Change In Account Payable | $513,000 | $-10,000 | $-169,000 | $165,000 |
| Change In Inventory | $-211,000 | $-340,000 | $324,000 | $-144,000 |
| Change In Receivables | $-1,362,000 | $438,000 | $-483,000 | $-745,000 |
| Changes In Account Receivables | $-1,362,000 | $438,000 | $-483,000 | $-745,000 |
| Other Non Cash Items | $-182,000 | $5,000 | $-1,717,000 | $-21,000 |
| Stock Based Compensation | $1,450,000 | $1,877,000 | $1,735,000 | $3,801,000 |
| Provisionand Write Offof Assets | $177,000 | $64,000 | $218,000 | $406,000 |
| Depreciation Amortization Depletion | $1,752,000 | $1,513,000 | $1,517,000 | $1,520,000 |
| Depreciation And Amortization | $1,752,000 | $1,513,000 | $1,517,000 | $1,520,000 |
| Depreciation | $1,752,000 | $1,513,000 | $1,517,000 | $1,520,000 |
| Net Income From Continuing Operations | $-363,000 | $-4,290,000 | $-5,853,000 | $-12,178,000 |
| Gain Loss On Sale Of Business | - | $0 | $-65,000 | $0 |
| Gain Loss On Investment Securities | - | - | - | $-606,000 |
| Sale Of PPE | - | - | - | - |
| Gain Loss On Sale Of PPE | - | - | - | - |
Fetched: 2026-06-18